TD Cowen Raises Agilent Technologies (A) Price Target to $196

TD Cowen reaffirms its Buy rating on Agilent Technologies with a new price target of $196, a 13.67% upside from the current price.

By EarningsIQ Research Desk · Published Oct 16, 2026, 2:09 PM EDT

Reviewed by automated data checks against the source data. How we make and check alerts

TD Cowen raised its price target on Agilent Technologies, Inc. ($A) to $196 from $180 on October 13, 2026, and rates the stock "Buy".

Since the rating, $A is up 0.8% to date (from the $171.60 close on Oct 13, 2026).

A Agilent Technologies, Inc.

$172.97 +26.33% year to date

Daily close · Oct 16, 2026

Key Points

TD Cowen reiterated its Buy rating on Agilent Technologies, Inc. with a new price target of $196 on October 13, 2026.
TD Cowen's $196 price target implies 13.67% upside from Agilent Technologies, Inc.'s ($A) current $172.43 share price.
Agilent shares are recently trading around $172.43, which is about 12% below the analyst's target.
This rating comes as Agilent prepares to report earnings on November 25, 2026, following a year of 8.1% revenue growth.

Get $A trade alerts by text

We text you when insiders, Congress or big funds trade $A. Free.

Not investment advice. EarningsIQ is not a registered investment adviser, and this automated Agilent Technologies, Inc. alert may contain errors. Disclosures

TD Cowen has reiterated its Buy rating on Agilent Technologies, Inc. (NYSE: A) with a new price target of $196 as of October 13, 2026. This is an increase from the previous target of $180. Currently, Agilent shares are trading at around $172.43, which places them about 12% below the new target set by TD Cowen.

Other Institutional Activity in Agilent Technologies

Several other institutional investors have also been active with Agilent Technologies. Blackrock Inc. trimmed its position by 303,054 shares, holding a total of 25,599,001 shares worth approximately $4.43 billion. Vanguard Capital Management LLC added 68,013 shares, bringing its total to 18,449,861 shares valued at around $3.19 billion. Vanguard Portfolio Management LLC increased its stake by 90,418 shares, totaling 14,442,441 shares worth about $2.50 billion. State Street Corporation also grew its holdings by 89,354 shares, ending with 12,854,230 shares valued at around $2.22 billion. However, Massachusetts Financial Services Co. reduced its stake significantly by 2,613,177 shares, now holding 10,010,867 shares worth about $1.73 billion.

Agilent Technologies, Inc. Stock Up 10.2%

Agilent Technologies is currently trading at $172.43, which is below the new price target of $196. This recent price reflects a 12% discount compared to the analyst's target and suggests potential for upward movement if the company meets its growth expectations.

12-month forecast

$A price target

Agilent Technologies, Inc. daily closes and this analyst's $196 target. Not advice.

Recent Earnings

Agilent reported trailing twelve-month revenue of approximately $7.37 billion and earnings per share of $5.07. The company has demonstrated solid performance with a net margin of 19.5% and a return on equity of 21.0%. The next earnings report is set for November 25, 2026.

Earnings drift grade

Outlook vs expectations on the last report — not price action.

D 39/100

Reported May 27, 2026

Forward outlook
5 target cuts vs 1 raises.
EPS & revenue
EPS beat estimates by 3.8%. Revenue met estimates.
Profit surprise
EBITDA missed by 4 percent. Operating income missed by 7 percent.
Pre-earnings setup
Bar was high, analysts already very bullish.
Analyst signal
1 upgrade, 1 target raise, 5 target cuts.
Earnings quality
Gross margin up 3.1 points. Operating margin up 3.8 points. Positive free cash flow.

Earnings Call Summary

Agilent delivered a strong second quarter with $1.83 billion in revenue, up 6.3 percent core growth and beating guidance by 80 basis points. Earnings per share came in at $1.49, beating expectations by 7 cents and growing 14 percent year over year. Operating margin expanded 130 basis points to 26.4 percent, well ahead of guidance. The company is seeing robust momentum across its instrument business with double digit growth in LC LCMS and GC driven by replacement cycles and share gains. Diagnostics grew 11 percent led by the Omnis family and cancer offerings. Strategic pricing delivered over 200 basis points of contribution, exceeding the annual target of 100 basis points at midyear. Management credited the Ignite operating system for driving execution excellence and structural improvements.

Guidance Management raised full year revenue and earnings guidance. The company now expects $7.39 to $7.49 billion in annual revenue with core growth of 4.5 to 6.0 percent, up 30 basis points from prior guidance. Earnings per share guidance increased to $6.00 to $6.10, up 8 cents at the midpoint. For the third quarter, they forecast $1.83 to $1.85 billion in revenue with EPS of $1.48 to $1.50.

Clearly negative report. The company missed important expectations and likely triggers downward revisions.

Dividend

Agilent pays an annual dividend of $1.02 per share, which translates to a yield of approximately 0.6%. The company's dividend payout ratio is 20%, indicating a sustainable approach to returning value to shareholders.

Insider Buying and Selling at Agilent Technologies, Inc.

Insider transactions show some activity, with Officer Rodney Gonsalves selling 3,000 shares on November 26, 2025, at an average price of $154.99, totaling about $464,956. Director Mikael Dolsten also sold 2,600 shares on December 1, 2025, for about $389,511. In addition, Dolsten sold 1,600 shares at $135.42 on May 29, 2026, valued at $216,672, and another 634 shares at $151.38 on September 4, 2026, worth about $95,972. All these transactions occurred before the current rating announcement.

Analysts Set New Price Targets

On October 13, 2026, TD Cowen maintained its Buy rating on Agilent Technologies with a target price of $196. Also on the same day, Morgan Stanley maintained an Overweight rating with a target of $190. Earlier, Barclays maintained an Overweight rating with a target of $195 on October 7, 2026. The consensus among analysts suggests a positive outlook for Agilent, with multiple firms supporting a Buy or Overweight rating.

About Agilent Technologies

Agilent Technologies, Inc. provides solutions for the life sciences, diagnostics, and applied chemical markets globally. The company operates through three segments: Life Sciences and Diagnostics Markets, Agilent CrossLab, and Applied Markets. Its focus on innovation is key as it prepares for its upcoming earnings report and continues to attract institutional interest.

Bottom Line

Investors should keep an eye on Agilent Technologies as it approaches its earnings date on November 25, 2026. The recent analyst ratings indicate confidence in the company's growth potential despite the current share price being below the new target set by TD Cowen.